Clinical Study

Cysticerci Drive Dendritic Cells to Promote In Vitro and In Vivo Tregs Differentiation

Table 2

Phenotype of peripheral dendritic and regulatory T cells in NC patients and healthy subjects.

PhenotypeNC patientsHealthy subjectsP

Dendritic cells
SLAM+CD11C+9.65 ± 5.663.80 ± 1.880.045
CD205+CD11C+21.55 ± 13.644.27 ± 3.120.014
ILT3+CD11C+35.01 ± 27.6131.48 ± 28.700.813
HLA-DR+CD11C+71.47 ± 19.8769.05 ± 12.960.805
CD86+CD11C+39.70 ± 25.8754.21 ±12.450.250
CD40+CD11C+7.92 ± 7.982.81 ± 1.490.182
T cells
CD4+CD25 High  
FoxP3+CD127−/low
14.22 ± 9.084.35 ± 4.260.0194
T lymphocytes30.85 ± 11.4943.59 ± 5.600.07